VIVXF (Avivagen) Total Noninterest Expense

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Avivagen Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

Avivagen Business Description

Address 100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc. is a Canadian life sciences company that develops and commercializes animal health products based on its proprietary OxC-beta technology, derived from carotenoid compounds found in certain fruits and vegetables. Its lead product, OxC-beta Livestock, is a non-antibiotic feed additive designed to support immune function and promote health and growth in livestock, serving as an alternative to in-feed antibiotics used as growth promoters. The company targets livestock producers, feed manufacturers, and animal nutrition companies, with primary markets in Canada, the United States, and other regions where regulators and producers are reducing antibiotic use in animal agriculture. Avivagen generates revenue through product sales and distribution partnerships. The company has faced financial difficulties in recent years, including insolvency proceedings, which have affected its operations and commercial activities.